Report copyright - Immuno-oncology Trial Endpoints: Capturing Clinically ...described as immuno-oncology (I-O; ref. 1, 2). I-O, particu-larly the novel class of immune-checkpoint inhibitors (ICI), has
Please pass captcha verification before submit form